Q4 2023 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q4 and FY '23 Earnings Conference Call of Eris Lifesciences Limited.
We have with us on the call today Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director.
(Operator Instructions)
Please note that this conference is being recorded. I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company.
Thank you, and over to you, sir.
Thank you. Good afternoon, and welcome to our fourth quarter conference call. I'm Krishnakumar, and I'll be sharing the highlights of the quarter and full year review. We have reported stand-alone revenues of INR 315 crores in quarter 4 which represents a growth of 11.5%. Our stand-alone revenue for FY '23 stands at INR 1,331 crores, which represents a growth of 9.5%. This has been lower than our guidance due to a couple of factors.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
